Titre : Hypersensibilité retardée

Hypersensibilité retardée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cell Cycle Checkpoints
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypersensibilité retardée : Questions médicales les plus fréquentes", "headline": "Hypersensibilité retardée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypersensibilité retardée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-04", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypersensibilité retardée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hypersensibilité", "url": "https://questionsmedicales.fr/mesh/D006967", "about": { "@type": "MedicalCondition", "name": "Hypersensibilité", "code": { "@type": "MedicalCode", "code": "D006967", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Eczéma de contact allergique", "alternateName": "Dermatitis, Allergic Contact", "url": "https://questionsmedicales.fr/mesh/D017449", "about": { "@type": "MedicalCondition", "name": "Eczéma de contact allergique", "code": { "@type": "MedicalCode", "code": "D017449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dermatite photoallergique", "alternateName": "Dermatitis, Photoallergic", "url": "https://questionsmedicales.fr/mesh/D017454", "about": { "@type": "MedicalCondition", "name": "Dermatite photoallergique", "code": { "@type": "MedicalCode", "code": "D017454", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.150.600" } } }, { "@type": "MedicalWebPage", "name": "Dermatite de contact au Rhus toxicodendron", "alternateName": "Dermatitis, Toxicodendron", "url": "https://questionsmedicales.fr/mesh/D011040", "about": { "@type": "MedicalCondition", "name": "Dermatite de contact au Rhus toxicodendron", "code": { "@type": "MedicalCode", "code": "D011040", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.150.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Sarcoïdose", "alternateName": "Sarcoidosis", "url": "https://questionsmedicales.fr/mesh/D012507", "about": { "@type": "MedicalCondition", "name": "Sarcoïdose", "code": { "@type": "MedicalCode", "code": "D012507", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sarcoïdose pulmonaire", "alternateName": "Sarcoidosis, Pulmonary", "url": "https://questionsmedicales.fr/mesh/D017565", "about": { "@type": "MedicalCondition", "name": "Sarcoïdose pulmonaire", "code": { "@type": "MedicalCode", "code": "D017565", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575.725" } } }, { "@type": "MedicalWebPage", "name": "Uvéoparotidite", "alternateName": "Uveoparotid Fever", "url": "https://questionsmedicales.fr/mesh/D014608", "about": { "@type": "MedicalCondition", "name": "Uvéoparotidite", "code": { "@type": "MedicalCode", "code": "D014608", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575.865" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Hypersensibilité retardée", "alternateName": "Hypersensitivity, Delayed", "code": { "@type": "MedicalCode", "code": "D006968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elizabeth J Phillips", "url": "https://questionsmedicales.fr/author/Elizabeth%20J%20Phillips", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org." } }, { "@type": "Person", "name": "Shuen-Iu Hung", "url": "https://questionsmedicales.fr/author/Shuen-Iu%20Hung", "affiliation": { "@type": "Organization", "name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw." } }, { "@type": "Person", "name": "Andrew Gibson", "url": "https://questionsmedicales.fr/author/Andrew%20Gibson", "affiliation": { "@type": "Organization", "name": "Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia." } }, { "@type": "Person", "name": "Chuang-Wei Wang", "url": "https://questionsmedicales.fr/author/Chuang-Wei%20Wang", "affiliation": { "@type": "Organization", "name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China." } }, { "@type": "Person", "name": "Wen-Hung Chung", "url": "https://questionsmedicales.fr/author/Wen-Hung%20Chung", "affiliation": { "@type": "Organization", "name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37516418", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.actbio.2023.07.042" } }, { "@type": "ScholarlyArticle", "name": "Pro-Apoptotic Activity and Cell Cycle Arrest of", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37298837", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules28114361" } }, { "@type": "ScholarlyArticle", "name": "Cell Cycle Regulation by Integrin-Mediated Adhesion.", "datePublished": "2022-08-14", "url": "https://questionsmedicales.fr/article/36010598", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11162521" } }, { "@type": "ScholarlyArticle", "name": "Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis.", "datePublished": "2023-07-13", "url": "https://questionsmedicales.fr/article/37451663", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cbi.2023.110634" } }, { "@type": "ScholarlyArticle", "name": "Mitochondrial Metabolism in X-Irradiated Cells Undergoing Irreversible Cell-Cycle Arrest.", "datePublished": "2023-01-17", "url": "https://questionsmedicales.fr/article/36768155", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24031833" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Hypersensibilité", "item": "https://questionsmedicales.fr/mesh/D006967" }, { "@type": "ListItem", "position": 4, "name": "Hypersensibilité retardée", "item": "https://questionsmedicales.fr/mesh/D006968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypersensibilité retardée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypersensibilité retardée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypersensibilité retardée", "description": "Comment diagnostiquer l'hypersensibilité retardée ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes indiquent une hypersensibilité retardée ?\nPeut-on diagnostiquer par des analyses sanguines ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypersensibilité retardée", "description": "Quels sont les symptômes courants ?\nLes symptômes apparaissent-ils immédiatement ?\nY a-t-il des symptômes systémiques ?\nComment se manifeste une réaction cutanée ?\nLes symptômes varient-ils d'une personne à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypersensibilité retardée", "description": "Comment prévenir l'hypersensibilité retardée ?\nLes tests d'allergie aident-ils à la prévention ?\nLes changements de mode de vie sont-ils nécessaires ?\nLes médicaments préventifs sont-ils disponibles ?\nComment gérer les expositions accidentelles ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypersensibilité retardée", "description": "Quel est le traitement principal de l'hypersensibilité retardée ?\nLes antihistaminiques sont-ils efficaces ?\nComment les corticostéroïdes aident-ils ?\nY a-t-il des traitements topiques recommandés ?\nLes traitements sont-ils différents pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypersensibilité retardée", "description": "Quelles complications peuvent survenir ?\nL'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?\nY a-t-il un risque d'anaphylaxie ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications nécessitent-elles une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypersensibilité retardée", "description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il le risque d'hypersensibilité ?\nLes professions exposées sont-elles à risque ?\nLe stress peut-il aggraver l'hypersensibilité ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hypersensibilité retardée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical et des tests cutanés spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de patch et les tests de stimulation lymphocytaire sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une hypersensibilité retardée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons et rougeurs apparaissent après exposition à l'allergène." } }, { "@type": "Question", "name": "Peut-on diagnostiquer par des analyses sanguines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les analyses sanguines ne sont pas spécifiques, mais peuvent aider à évaluer l'inflammation." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les allergènes potentiels et les antécédents d'exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent éruptions cutanées, démangeaisons, et parfois fièvre." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils immédiatement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils apparaissent généralement 24 à 72 heures après l'exposition à l'allergène." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes systémiques comme la fièvre ou la fatigue peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Comment se manifeste une réaction cutanée ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La réaction cutanée se manifeste par des rougeurs, des vésicules et un gonflement localisé." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus." } }, { "@type": "Question", "name": "Comment prévenir l'hypersensibilité retardée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition aux allergènes connus est la meilleure méthode de prévention." } }, { "@type": "Question", "name": "Les tests d'allergie aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests d'allergie peuvent identifier les allergènes à éviter pour prévenir les réactions." } }, { "@type": "Question", "name": "Les changements de mode de vie sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des changements de mode de vie, comme éviter certains aliments ou produits, peuvent être nécessaires." } }, { "@type": "Question", "name": "Les médicaments préventifs sont-ils disponibles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques peuvent être pris en prévention avant une exposition connue." } }, { "@type": "Question", "name": "Comment gérer les expositions accidentelles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Avoir un plan d'action et des médicaments d'urgence peut aider à gérer les expositions accidentelles." } }, { "@type": "Question", "name": "Quel est le traitement principal de l'hypersensibilité retardée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal consiste en l'évitement de l'allergène et l'utilisation de corticostéroïdes." } }, { "@type": "Question", "name": "Les antihistaminiques sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antihistaminiques peuvent soulager les démangeaisons, mais ne traitent pas la cause." } }, { "@type": "Question", "name": "Comment les corticostéroïdes aident-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes réduisent l'inflammation et soulagent les symptômes cutanés." } }, { "@type": "Question", "name": "Y a-t-il des traitements topiques recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des crèmes ou pommades corticostéroïdes peuvent être appliquées sur les zones affectées." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la gravité des symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections cutanées peuvent survenir si les lésions sont grattées." } }, { "@type": "Question", "name": "L'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions répétées peuvent contribuer à des maladies cutanées chroniques." } }, { "@type": "Question", "name": "Y a-t-il un risque d'anaphylaxie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'anaphylaxie est rare dans l'hypersensibilité retardée, mais des réactions sévères peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent entraîner des douleurs, des démangeaisons et une gêne sociale." } }, { "@type": "Question", "name": "Les complications nécessitent-elles une hospitalisation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas graves, une hospitalisation peut être nécessaire pour un traitement intensif." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque principaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies, l'exposition répétée et la génétique sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hypersensibilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus à risque." } }, { "@type": "Question", "name": "Les professions exposées sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines professions, comme celles en contact avec des produits chimiques, présentent un risque accru." } }, { "@type": "Question", "name": "Le stress peut-il aggraver l'hypersensibilité ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et augmenter la sensibilité aux allergènes." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial d'allergies peut augmenter le risque d'hypersensibilité retardée." } } ] } ] }

Sources (10000 au total)

Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.

Radiotherapy is a mainstream modality for breast cancer treatment that employs ionizing radiation (IR) to damage tumor cell DNA and elevate ROS stress, which demonstrates multiple clinically-favorable...

Chlorogenic acid induces apoptosis and cell-cycle arrest in colorectal cancer cells.

Apoptotic agents from natural products like phenolic compounds can be used effectively in the treatment of cancer. Chlorogenic acid (CGA) is one of the phenolic compounds in medicinal plants with anti... HT-29 and HEK-293 cells were cultured after MTT assay for 24 h with CGA 100 µM, and without CGA. Then, flow cytometry assays and the expression of apoptosis-related genes including caspase 3 and 9, Bc... The cell viability of all two-cell lines decreased in a dose-dependent manner. Moreover, CGA induces cell cycle arrest in HT-29 cells by increasing the expression of P21 and P53. It also induces apopt... Considering the cytotoxicity and cell cycle arrest and induction of apoptosis in the colon cancer cell line by CGA, it can be concluded that CGA is a suitable option for the treatment of colon cancer....

Quercetin Induces Cell Cycle Arrest and Apoptosis in YD10B and YD38 Oral Squamous Cell Carcinoma Cells.

Oral squamous cell carcinoma (OSCC) exhibits the highest lethality among head and neck cancers. Treatment for OSCC is limited due to diverse side effects. Quercetin is a natural flavonoid compound fou... For our study, two different types of OSCC cells were used. YD10B cells are tongue SCC cells with the p53 mutation and YD38 cells are lower gingiva SCC cells without the p53 mutation, respectively. Th... Our results showed that quercetin decreased cell viability and induced G1 cell cycle arrest in YD10B and YD38 OSCC cells. Moreover, quercetin remarkably decreased the expression of cell cycle upregula... In conclusion, this study demonstrates that quercetin shows different anti-cancer responses in OSCC with and without p53 mutation, respectively. Despite different p53 status in OSCC cells, quercetin l...